acne
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis conforms to the diagnostic criteria for common acne with lung meridian wind-heat syndrome; Meets the classification standards of the Pillsbury grading method for grades I and II; Patients with a score of =30 according to the GAGS scoring criteria; Outpatients with common acne aged 14-40 years old; Patients have no cognitive impairments voluntarily accept the trial and commit to actively cooperating with the research having thoroughly read and signed the informed consent form; Adhere to the lifestyle precautions stipulated throughout the study period willing to exclusively use the non-medicated facial cleanser and moisturizer provided by this study and not use other acne treatments.
Exclusion criteria
Exclusion criteria: 1. Individuals who have used topical or oral anti-androgens antibiotics retinoids or other acne treatments within the last month; those who have undergone radiotherapy within the last 2 weeks; 2. Individuals with open wounds on the face that are in the process of healing those with infectious skin diseases; patients with severe primary diseases of the circulatory respiratory or other systems that cannot be controlled with regular medication; individuals with sunburn on the face; 3. Subjects with severe liver kidney cardiovascular respiratory endocrine hematological urinary metabolic central nervous system diseases or autoimmune diseases; 4. Those who are pregnant breastfeeding or under stress conditions such as trauma; 5. Individuals who have participated in other clinical trials within the last month; 6. Anyone who has had a systemic or local allergic reaction to any of the components of this medication. Any individual meeting any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness rate of the acne severity score; | — |
Secondary
| Measure | Time frame |
|---|---|
| brown zone;sebum;pH;degree of hydration;red zone;brown zone;DLQI;porphyrins;sclererythrin;pores; | — |
Countries
China
Contacts
China-Japan Friendship Hospital